TY - JOUR
T1 - Healthy for My Baby Research Protocol- a Randomized Controlled Trial Assessing a Preconception Intervention to Improve the Lifestyle of Overweight Women and Their Partners
AU - Hardy, Isabelle
AU - Lloyd, Amanda
AU - Morisset, Anne Sophie
AU - Camirand Lemyre, Felix
AU - Baillargeon, Jean Patrice
AU - Fraser, William D.
N1 - Funding Information:
This study is funded through the Canada Research Chairs program (Tier 1 CIHR Chair 950-229983), the Structuring Projects Competition of the CHUS Research Center, the Clinician-Investigator Funding Program of the University of Sherbrooke Department of Medicine, and the Internal Funding Program of the University of Sherbrooke Department of Obstetrics and Gynecology. The funding bodies had no role in designing this study or in writing this manuscript.
Funding Information:
46. Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines. In: Rasmussen KM, Yaktine AL, editors. The National Academies Collection: Reports funded by National Institutes of Health. Washington, DC: National Academies Press (US) (2009). Available online at: http://www.ncbi.nlm.nih.gov/books/NBK32813/ (accessed November 5, 2018).
Publisher Copyright:
© Copyright © 2021 Hardy, Lloyd, Morisset, Camirand Lemyre, Baillargeon and Fraser.
PY - 2021/8/3
Y1 - 2021/8/3
N2 - Background: Preconception lifestyle interventions appear promising to reduce pregnancy complications, prevent adult cardiometabolic diseases, and prevent childhood obesity. These interventions have almost exclusively been studied in populations of obese infertile women. The development of preconception lifestyle interventions targeting a broader population of overweight and obese women without a history infertility and their partners is needed. Methods: This study is a multicenter open label parallel group randomized controlled trial. Sixty-eight non-infertile women with overweight or obesity in the preconception period and their partners will be recruited from the Sherbrooke and Quebec City regions. The couples will be randomized in a 1:1 ratio to receive the Healthy for my Baby intervention or standard care in the preconception period and pregnancy. Women and their partners will be invited to take part in this lifestyle intervention which includes motivational interviews and daily self-monitoring of lifestyle goals through a mobile phone application. The primary endpoint of this study is the diet quality of women during the preconception period, which will be evaluated using the C-HEI 2007 score at baseline, 2, 4- and 6-months following study enrolment. Women's dietary quality will also be evaluated through the measure of urinary biomarkers of habitual dietary intake at baseline and 2 months in preconception, and 24–26 weeks in pregnancy. Additional indicators of women's lifestyle as well as anthropometric measures will be documented in preconception and pregnancy. For the pregnancy period, the main secondary endpoint is the pattern of gestational weight gain. Pregnancy and neonatal complications will also be evaluated. For partners, diet quality, other lifestyle habits, and anthropometric measures will be documented in the preconception and pregnancy periods. Discussion: This study will evaluate the effectiveness of a low-cost intervention designed to improve diet and other lifestyle characteristics of women in the preconception period who are overweight or obese. If the Healthy for my Baby intervention is efficacious regarding dietary measures, larger trials will be needed to evaluate the impact of this intervention on the rates of pregnancy complications, childhood obesity, and adult cardiometabolic disease. Clinical Trial Registration: clinicaltrials.gov (NCT04242069).
AB - Background: Preconception lifestyle interventions appear promising to reduce pregnancy complications, prevent adult cardiometabolic diseases, and prevent childhood obesity. These interventions have almost exclusively been studied in populations of obese infertile women. The development of preconception lifestyle interventions targeting a broader population of overweight and obese women without a history infertility and their partners is needed. Methods: This study is a multicenter open label parallel group randomized controlled trial. Sixty-eight non-infertile women with overweight or obesity in the preconception period and their partners will be recruited from the Sherbrooke and Quebec City regions. The couples will be randomized in a 1:1 ratio to receive the Healthy for my Baby intervention or standard care in the preconception period and pregnancy. Women and their partners will be invited to take part in this lifestyle intervention which includes motivational interviews and daily self-monitoring of lifestyle goals through a mobile phone application. The primary endpoint of this study is the diet quality of women during the preconception period, which will be evaluated using the C-HEI 2007 score at baseline, 2, 4- and 6-months following study enrolment. Women's dietary quality will also be evaluated through the measure of urinary biomarkers of habitual dietary intake at baseline and 2 months in preconception, and 24–26 weeks in pregnancy. Additional indicators of women's lifestyle as well as anthropometric measures will be documented in preconception and pregnancy. For the pregnancy period, the main secondary endpoint is the pattern of gestational weight gain. Pregnancy and neonatal complications will also be evaluated. For partners, diet quality, other lifestyle habits, and anthropometric measures will be documented in the preconception and pregnancy periods. Discussion: This study will evaluate the effectiveness of a low-cost intervention designed to improve diet and other lifestyle characteristics of women in the preconception period who are overweight or obese. If the Healthy for my Baby intervention is efficacious regarding dietary measures, larger trials will be needed to evaluate the impact of this intervention on the rates of pregnancy complications, childhood obesity, and adult cardiometabolic disease. Clinical Trial Registration: clinicaltrials.gov (NCT04242069).
KW - biomarkers/urine
KW - health technology
KW - lifestyle intervention
KW - metabolomics
KW - overweight and obesity
KW - preconception care
KW - pregnancy
KW - randomized controlled trial
KW - Life Style
KW - Gestational Weight Gain
KW - Humans
KW - Overweight/prevention & control
KW - Male
KW - Randomized Controlled Trials as Topic
KW - Pregnancy
KW - Multicenter Studies as Topic
KW - Adult
KW - Female
UR - http://www.scopus.com/inward/record.url?scp=85113195818&partnerID=8YFLogxK
U2 - 10.3389/fpubh.2021.670304
DO - 10.3389/fpubh.2021.670304
M3 - Article
C2 - 34414154
AN - SCOPUS:85113195818
SN - 2296-2565
VL - 9
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 670304
ER -